- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07916428
AI-Based Model for Predicting Type 2 Diabetes Risk Using Lifestyle Factors Among Senior Nursing Students (AI-T2DM-NS)
Developing an Artificial Intelligence-Based Model for Predicting Type 2 Diabetes Risk Using Lifestyle Factors Among Senior Nursing Students at Alexandria University
This study will develop and test an artificial intelligence (AI) model that estimates the risk of type 2 diabetes among senior (third- and fourth-year) nursing students at the Faculty of Nursing, Alexandria University, Egypt. Type 2 diabetes is common in Egypt, and many cases are not diagnosed. Daily habits such as diet, physical activity, and body weight play a major role in who develops it. Nursing students will become health care providers who teach patients about healthy living, so it is important to find those who may be at risk early.
About 200 students will take part. Each student will complete a questionnaire about personal information and the Health-Promoting Lifestyle Profile II, which measures health habits such as nutrition, physical activity, stress management, and health responsibility. The researcher will measure height, weight, waist size, and blood pressure. Each student's diabetes risk will be scored using the Arabic version of the Australian Type 2 Diabetes Risk Assessment Tool (AUSDRISK), which classifies risk as low, moderate, or high.
These data will be used to build a machine learning model that predicts each student's diabetes risk level from lifestyle and body measurement factors, and shows which factors influenced the prediction most. Students will then try the model and rate how useful and easy to use it is.
No treatment or intervention will be given. The study aims to support early identification of students at risk and to provide a model that nursing education programs and community health nurses could use in preventive health efforts.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Stimato)
Contatti e Sedi
Contatto studio
- Nome: Dr. Mohamed Fakhry Ahmed Salem, PhD
- Numero di telefono: 01286038014
- Email: Mohamed.Fakhry@alexu.edu.eg
Luoghi di studio
-
-
-
Alexandria, Egitto, 21511
- Faculty of Nursing, Alexandria University
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Third- and fourth-year (senior) undergraduate nursing students, male and female, enrolled at the Faculty of Nursing, Alexandria University, Egypt, who do not have diabetes or endocrine disorders affecting glucose metabolism and are not pregnant.
Descrizione
Inclusion Criteria:
- Regularly enrolled third- or fourth-year (senior) undergraduate nursing students at the Faculty of Nursing, Alexandria University.
- Willing to provide written informed consent and participate voluntarily.
- Have access to an internet-enabled electronic device (smartphone, tablet, or computer) and basic digital literacy.
Exclusion Criteria:
- Previously diagnosed with type 1 or type 2 diabetes mellitus.
- Chronic endocrine disorders known to affect glucose metabolism.
- Pregnancy.
- Incomplete or invalid questionnaire responses.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Modelli osservazionali: CASE_CONTROL
- Prospettive temporali: CROSS_SECTIONAL
Coorti e interventi
Gruppo / Coorte |
Intervento / Trattamento |
|---|---|
|
Senior Nursing Students
Description: Stratified random sample of third- and fourth-year (senior) nursing students at the Faculty of Nursing, Alexandria University, who complete the questionnaires and anthropometric measurements, contribute data for developing the AI model, and then try the model and rate its usefulness and ease of use. |
A machine learning model developed from students' lifestyle (HPLP-II), anthropometric, and blood pressure data to predict type 2 diabetes risk level (low, moderate, high) and identify the most influential factors. Students will use the model once and rate its usefulness and ease of use. No treatment or lifestyle intervention is delivered |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Type 2 Diabetes Risk Level According to AUSDRISK
Lasso di tempo: aseline (single assessment at data collection, up to 1 day per participant)
|
Proportion of senior nursing students classified as low risk (total score 4 or less), moderate risk (5 to 10), or high risk (11 or more) for developing type 2 diabetes, using the Arabic version of the Australian Type 2 Diabetes Risk Assessment Tool (AUSDRISK). Total score ranges from 0 to 34; higher scores indicate higher risk. |
aseline (single assessment at data collection, up to 1 day per participant)
|
|
Performance of the AI-Based Diabetes Risk Prediction Model
Lasso di tempo: Upon completion of data collection and model development (up to 6 months after study start)
|
Accuracy, sensitivity, specificity, and area under the receiver operating characteristic curve (AUC) of the machine learning model in classifying students into low, moderate, or high AUSDRISK risk categories, assessed on a held-out test set. |
Upon completion of data collection and model development (up to 6 months after study start)
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Health-Promoting Lifestyle Profile II (HPLP-II) Score
Lasso di tempo: Baseline (single assessment at data collection)
|
Total and subscale scores (health responsibility, physical activity, nutrition, spiritual growth, interpersonal relations, stress management) of the 52-item Arabic HPLP-II, rated on a 4-point scale (1 = never to 4 = routinely). Higher scores indicate more frequent health-promoting behaviors. |
Baseline (single assessment at data collection)
|
|
Perceived Usefulness and Ease of Use of the AI Model
Lasso di tempo: Immediately after the student uses the AI model (single assessment)
|
Scores on a 12-item questionnaire (6 items on perceived usefulness, 6 on perceived ease of use) rated on a 7-point scale (1 = strongly disagree to 7 = strongly agree). Higher scores indicate better perceived usefulness and ease of use. |
Immediately after the student uses the AI model (single assessment)
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Dr. Mohamed Fakhry Ahmed Salem, Alexandria University
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- AU-20-6-242
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .